home / stock / hcat / hcat news


HCAT News and Press, Health Catalyst Inc From 05/11/22

Stock Information

Company Name: Health Catalyst Inc
Stock Symbol: HCAT
Market: NYSE
Website: healthcatalyst.com

Menu

HCAT HCAT Quote HCAT Short HCAT News HCAT Articles HCAT Message Board
Get HCAT Alerts

News, Short Squeeze, Breakout and More Instantly...

HCAT - Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q1 2022 Results - Earnings Call Transcript

Health Catalyst, Inc. (HCAT) Q1 2022 Earnings Conference Call May 10, 2022 5:00 PM ET Company Participants Adam Brown - IR Dan Burton - CEO Bryan Hunt - CFO Conference Call Participants Anne Samuel - JPMorgan Ryan Daniels - William Blair Jessica Tassan - Piper Sandler Cindy Motz - Goldman Sac...

HCAT - Health Catalyst acquires data management company ARMUS

Healthcare data and analytics technology and services provider Health Catalyst (NASDAQ:HCAT) has acquired ARMUS Corp. for an undisclosed sum. ARMUS provides data abstraction, data validation, data management, data submission, and data reporting services to support participation in clinic...

HCAT - Health Catalyst Acquires ARMUS; Bolsters Clinical Quality Offering and Outsourced Services

Health Catalyst Acquires ARMUS; Bolsters Clinical Quality Offering and Outsourced Services PR Newswire SALT LAKE CITY , May 11, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technolo...

HCAT - Health Catalyst Inc (HCAT) Q1 2022 Earnings Call Transcript

Image source: The Motley Fool. Health Catalyst Inc (NASDAQ: HCAT) Q1 2022 Earnings Call May 10, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Health Catalyst Inc (HCAT) Q1 2022 Earnings Call Transcript

HCAT - Health Catalyst Non-GAAP EPS of -$0.06 beats by $0.05, revenue of $68.09M beats by $2.08M

Health Catalyst press release (NASDAQ:HCAT): Q1 Non-GAAP EPS of -$0.06 beats by $0.05. Revenue of $68.09M (+21.9% Y/Y) beats by $2.08M. For Q2: Revenue is expected to be between $68.0M and $71.0M (vs. consensus of $70.92M). For FY22: Revenue is expected to be between $287.8M and $292.8M (vs. ...

HCAT - Health Catalyst Reports First Quarter 2022 Results

SALT LAKE CITY, May 10, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2022. “I...

HCAT - Health Catalyst to Announce First Quarter 2022 Operating Results and Host Conference Call on Tuesday, May 10, 2022

SALT LAKE CITY, April 26, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2022 operating results on Tuesday, May 10, 2022, after mar...

HCAT - Teladoc, 1Life among health tech stocks exposed to recession - Citi

Citi Investment Research has grouped telehealth provider, Teladoc Health (NYSE:TDOC) and membership-based primary care platform 1Life Healthcare (ONEM) among health tech stocks highly exposed to the risk of a recession. This month, the economists polled by The Wall Street Journal&#x...

HCAT - SRAD, ZYXI and HCAT among after hour movers

Gainers: Sportradar Group AG (SRAD) +5%. Eargo, Inc. (EAR) +4%. Zynex, Inc. (ZYXI) +3%. IVERIC bio, Inc. (ISEE) +3%. Sono Group N.V. (SEV) +3%. Losers: Vir Biotechnology, Inc. (VIR) -8%. Jounce Therapeutics, Inc. (JNCE) -6%. Travelzoo (TZOO) -5%. Health Catalyst, Inc (HCAT) -4%...

HCAT - Health Catalyst upgraded at Jefferies on recent pullback in shares

Citing an approximately 60% decline in its shares price over the past six months, Jefferies has upgraded the data and analytics-focused health tech company Health Catalyst (HCAT +10.6%) to Buy from Hold on Thursday. In addition to recent weakness in shares, the analysts led by Glen Santangelo...

Previous 10 Next 10